| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 07/11/2013 | US20130178478 Pyridazine amide compounds |
| 07/11/2013 | US20130178472 Arylsulfonamide pyridine-pyridinone derivatives, preparation of same, and therapeutic use thereof |
| 07/11/2013 | US20130178465 Intranasal dexmedetomidine compositions and methods of use thereof |
| 07/11/2013 | US20130178464 Delta crystalline form of the arginine salt of perindopril, a process for its preparation, and pharmaceutical compositions containing it |
| 07/11/2013 | US20130178460 Thienopyrimidine compounds |
| 07/11/2013 | US20130178454 Combination of testosterone and ornithine decarboxylase (odc) inhibitors |
| 07/11/2013 | US20130178453 Cannabinoid Agonists |
| 07/11/2013 | US20130178450 Methods for increasing the production or activity of catalase |
| 07/11/2013 | US20130178445 Novel Benzopyran Compounds, Compositions and Uses Thereof |
| 07/11/2013 | US20130178443 Phenylquinazoline derivatives |
| 07/11/2013 | US20130178440 Compositions and methods for treating skin cancer associated diseases |
| 07/11/2013 | US20130178439 Methods of treating an inflammatory-related disease |
| 07/11/2013 | US20130178424 Therapy for complications of diabetes |
| 07/11/2013 | US20130178413 Hcv ns3 protease inhibitors |
| 07/11/2013 | US20130177647 Methods for manipulating satiety |
| 07/11/2013 | US20130177644 Methods for treating multiple myeloma with 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione |
| 07/11/2013 | US20130177642 Methods for treating multiple myeloma with 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione |
| 07/11/2013 | US20130177632 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents |
| 07/11/2013 | US20130177627 Growth inhibitory effects of nanoparticles containing triterpene glycosides or triterpenes |
| 07/11/2013 | US20130177626 Pharmaceutical compositions comprising cyclosporin |
| 07/11/2013 | US20130177625 Immunogenic compositions and methods for treating neoplasia |
| 07/11/2013 | US20130177624 Mirna expression in allergic disease |
| 07/11/2013 | US20130177607 Nanocell Drug Delivery System |
| 07/11/2013 | US20130177604 Compositions and Methods of Treating Metabolic Disorders |
| 07/11/2013 | US20130177600 Materials and Methods for Altering an Immune Response to Exogenous and Endogenous Immunogens, Including Syngeneic and Non-Syngeneic Cells, Tissues or Organs |
| 07/11/2013 | US20130177590 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 07/11/2013 | US20130177582 Parapoxvirus expressing the vp60 major capsid protein of the rabbit haemorrhagic disease virus |
| 07/11/2013 | US20130177577 Nlrc5 as a target to intervene mhc class 1-mediated immune responses |
| 07/11/2013 | US20130177571 Anti-Mesothelin Antibodies |
| 07/11/2013 | US20130177556 Egfr aptamer inhibitor for use in therapy and diagnosis |
| 07/11/2013 | US20130177554 Neuropilin as a biomarker for bevacizumab combination therapies |
| 07/11/2013 | US20130177549 Treatment of Synucleinopathies |
| 07/11/2013 | US20130177548 Treating neoplasms with neurotoxin |
| 07/11/2013 | US20130177546 Method for enhancing efficacy and selectivity of cancer cell killing by dna damaging agents |
| 07/11/2013 | US20130177543 Natural Means of Augmenting Endogenous Stem Cell Numbers |
| 07/11/2013 | US20130177531 Inhibitors of Serine Proteases |
| 07/11/2013 | US20130177530 Antiviral compounds |
| 07/11/2013 | US20130177529 Pyrazole Compounds |
| 07/11/2013 | US20130177528 Compositions and methods for inhibiting viral infection |
| 07/11/2013 | US20130177522 Non-irritating opthalmic povidone-iodine compositions |
| 07/11/2013 | US20130177513 Extract of aerial parts of maca rich in polyphenols and composition comprising same |
| 07/11/2013 | US20130177498 Methods and compositions for immunotherapy and detection of inflammatory and immune-dysregulatory disease, infectious disease, pathologic angiogenesis and cancer |
| 07/10/2013 | EP2612672A1 Bioeffective krill oil compositions |
| 07/10/2013 | EP2612666A2 Treatments using citrulline |
| 07/10/2013 | EP2612663A1 Extended-release formulation for reducing the frequency of urination and method of use thereof |
| 07/10/2013 | EP2612662A1 Delayed-release formulation for reducing the frequency of urination and method of use thereof |
| 07/10/2013 | EP2612661A1 Delayed release formulation for reducing the frequency of urination and method of use thereof |
| 07/10/2013 | EP2612660A1 Extended-release formulation for reducing the frequency of urination and method of use thereof |
| 07/10/2013 | EP2612658A1 Pharmaceutical compositions of 4'-[(1,4'dimethyl-2'-propyl[2,6'-bi-1h-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid and is 6-chloro-3,4-dihydro-2h-1,2,4-benzothiadiazine-7-sulfonamide-1,1-dioxide |
| 07/10/2013 | EP2611902A2 Compositions and methods for modulating emt and uses thereof |
| 07/10/2013 | EP2611447A2 Formulation of comprising tiotropium and a calcium channel blocker |
| 07/10/2013 | EP2611439A1 Composition comprising a combination of dha and epa for administration prior to commencement of chemotherapy |
| 07/10/2013 | EP2611437A1 Pharmaceutical composition for prevention and treatment of amyotrophic lateral sclerosis |
| 07/10/2013 | EP2611436A1 Combination of hdac inhibitors with thrombocytopenia drugs |
| 07/10/2013 | CN1809340B Pharmaceutical products |
| 07/10/2013 | CN1541109B Inhibitors of HER3 activity |
| 07/10/2013 | CN103201290A S100a4 antibodies and therapeutic uses thereof |
| 07/10/2013 | CN103200955A Composition comprising a peptide and an inhibitor of viral neuraminidase |
| 07/10/2013 | CN103200943A Use of 2-carboxamide cycloamino urea derivatives in the treatment of EGFR dependent diseases or diseases that have acquired resistance to agents that target EGFR family members |
| 07/10/2013 | CN103200939A Composition comprising a combination of DHA and EPA for administration prior to commencement of chemotherapy |
| 07/10/2013 | CN103191440A Preparation method and application of pH sensitive drug delivery system with carbon nanomaterial as carrier |
| 07/10/2013 | CN103191430A Sustained release preparation for relieving frequent micturition and application method thereof |
| 07/10/2013 | CN103191429A Extended release formulation for relieving frequent micturition and application method thereof |
| 07/10/2013 | CN103191428A Akebia fruit seed extractive and cytotoxin antibiotic combined composition and application thereof |
| 07/10/2013 | CN103191412A Degradation of PA200 and acetylation-mediated core histones through proteasome |
| 07/10/2013 | CN102423488B Medicine composition used for treating herpes zoster |
| 07/10/2013 | CN102370763B Application of Chinese medicinal herb immature bitter orange extract in preparation of weight-reducing and lipid-lowering medicament or preparation of medicament having lipase activity suppressing effect |
| 07/10/2013 | CN102370694B Application of Chinese herbal medicine shrubby sophora extract in preparation of weight losing and lipid lowering medicament or medicament with lipase activity suppression effect |
| 07/10/2013 | CN102370689B Application of extracts of Chinese herbal medicine folium sennae in preparation of weight-losing and lipid-lowering medicines or medicines with function of inhibiting lipase activity |
| 07/10/2013 | CN102366433B Application of Chinese medicinal chrysanthemum extract in preparing medicaments with lipase activity-inhibiting action |
| 07/10/2013 | CN102357226B Application of Chinese herbal medicine turmeric extraction in preparation of drug with lipase activity inhibition effect |
| 07/10/2013 | CN102357150B Application of extractive of Chinese herbal medicine medlar to prepare medicines with effects of inhibiting lipase activity |
| 07/10/2013 | CN102357120B Application of extractive of Chinese herbal medicine scutellaria baicalensis to prepare medicines with effects of inhibiting lipase activity |
| 07/10/2013 | CN102357114B Application of Chinese herbal medicine kudzu root extracts in preparation of medicines with lipase activity inhibition effect |
| 07/10/2013 | CN102357113B Application of Chinese herbal medicine fiveleaf gynostemma in preparation of drug with lipase activity inhibition effect |
| 07/10/2013 | CN102357106B Application of Chinese herbal medicine campsis grandiflora extracts in preparation of weight-losing lipid-lowering medicines or medicines with lipase activity inhibition effect |
| 07/10/2013 | CN102319439B Drug with magnetic microspheres, and use thereof |
| 07/10/2013 | CN102139108B Co-ground materials of benzimidazoles proton pump inhibitors and hydrophilic polymer ground mixture |
| 07/10/2013 | CN102120030B Medicament of ilaprazole chemical structure and application thereof |
| 07/10/2013 | CN102112682B Structured forming fabric and papermaking machine |
| 07/10/2013 | CN101926770B Drug-loaded liposome and preparation method thereof |
| 07/10/2013 | CN101801391B Use of hyaluronic acid for preparing compositions particularly for improving the function of skin, eye and mucous membrane protection |
| 07/10/2013 | CN101516334B Stabilizing compositions for antibiotics and methods of use |
| 07/09/2013 | US8481801 Fluid wound dressing comprising partially cured polyurethane |
| 07/09/2013 | US8481599 Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholism |
| 07/09/2013 | US8481597 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
| 07/09/2013 | US8481575 Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| 07/09/2013 | US8481488 Compositions and methods for reducing the risk of preterm labor |
| 07/09/2013 | US8481078 Solid dosage form comprising a fibrate |
| 07/09/2013 | US8481025 Composition for maintaining healthy kidney function |
| 07/09/2013 | US8481015 Applying agmatine and a dermatologically acceptable carrier to the skin; inhibiting hair growth |
| 07/09/2013 | CA2761440C Fredericamycin derivatives |
| 07/09/2013 | CA2682736C Combined use of dipeptidyl peptidase 4 inhibitor and sweetener |
| 07/09/2013 | CA2577408C Use of (halobenzyloxy) benzylamino-propanamides for the manufacture of medicaments active as sodium and/or calcium channel selective modulators |
| 07/09/2013 | CA2445565C Compositions and methods of double-targeting virus infections and cancer cells |
| 07/09/2013 | CA2430702C Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 07/09/2013 | CA2369413C Transmembrane protein expressed in prostate and other cancers |
| 07/09/2013 | CA2354188C Cancer cell vaccine |
| 07/04/2013 | WO2013100874A1 Effervescent pregablin formulation |
| 07/04/2013 | WO2013098264A1 Inhibitor of trpm-4 ion channel for treating or preventing neurodegeneration |